Results of curative strategy in patients with peritoneal and extraperitoneal metastases from colorectal cancer

Background: Curative treatment of peritoneal metastases from colorectal cancer (CRPM) relies on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC). Benefits of this strategy remain uncertain when CRPM are associated with extraperitoneal metastases (EPM). The aim of this study was to compare outcomes of patients treated with CRS/HIPEC for CRPM, with or without EPM. Methods: This study included 331 consecutive patients...